Susan B Cicatelli

A Phase IIa Controlled Human Malaria Infection and Immunogenicity Study of RTS,S/AS01E and RTS,S/AS01B Delayed Fractional Dose Regimens in Malaria-Naive Adults

Linda A. Murray, N. Waters, E. Jongert, 2020, The Journal of infectious diseases.

Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study.

Paige E. Waterman, N. Waters, W. Robinson, 2016, The Journal of infectious diseases.

An open label study of the safety and efficacy of a single dose of weekly chloroquine and azithromycin administered for malaria prophylaxis in healthy adults challenged with 7G8 chloroquine-resistant Plasmodium falciparum in a controlled human malaria infection model

P. Waterman, J. Moon, J. Livezey, 2020, Malaria Journal.

An Open Label Study of the Safety and Efficacy of a Single Dose of Weekly Chloroquine and Azithromycin Administered for Malaria Prophylaxis in Healthy Adults Challenged with 7G8 Chloroquine-Resistant Plasmodium falciparum in a Controlled Human Malaria Infection (CHMI) Model

P. Waterman, J. Moon, J. Livezey, 2020 .

Protection against Plasmodium falciparum malaria by PfSPZ Vaccine.

Sumana Chakravarty, Joana C. Silva, S. Hoffman, 2017, JCI insight.

DNA Prime/Adenovirus Boost Malaria Vaccine Encoding P. falciparum CSP and AMA1 Induces Sterile Protection Associated with Cell-Mediated Immunity

D. Carucci, Awalludin Sutamihardja, A. J. McCoy, 2013, PloS one.

Determination of Cytochrome P450 Isoenzyme 2D6 (CYP2D6) Genotypes and Pharmacogenomic Impact on Primaquine Metabolism in an Active-Duty US Military Population

N. Waters, W. Mccarthy, Qigui Li, 2019, The Journal of infectious diseases.